SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
MEDP reported Third Quarter 2026 results. The stock moved -1.3% on the print.
MEDPearnings

Earnings reactions, page 14

Medpace Holdings, Inc. (MEDP) Q3 FY2026 earnings

October 22, 2026 · SharpeIQ Research Desk

Reported results

  • Revenue was $716.0 million for the third quarter of 2026.
  • Net new business awards were $873.4 million in the third quarter of 2026.
  • GAAP net income was $137.5 million, or $4.84 per diluted share, for the third quarter of 2026.
  • Net income margin (GAAP) was 19.2% for the third quarter of 2026.
  • EBITDA (non-GAAP) was $172.1 million for the third quarter of 2026.
  • EBITDA margin (non-GAAP) was 24.0% for the third quarter of 2026.

Guidance

  • 2026 revenue in the range of $2.835 billion to $2.855 billion.
  • GAAP net income for full year 2026 in the range of $514.0 million to $524.0 million.
  • Full year 2026 EBITDA (non-GAAP) in the range of $638.0 million to $652.0 million.
  • Diluted earnings per share (GAAP) forecasted in the range of $17.97 to $18.32.

Price and volatility reaction

The stock moved -1.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -34.1 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release662.482026-10-21
Close after release653.962026-10-22
Realised move-1.3%close to close
30d ATM IV change-34.1 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-21 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →